Making commonly used antimicrobial products like athlete’s foot, vaginal thrush treatments and cold sore creams available only with a prescription in Europe could cost the region close to €10bn ($10.6bn) a year in additional health expenses, according to IQVIA.
Over five years, this cost – which stems primarily from increased doctor’s visits (59m extra per year) and productivity losses – to Europe’s health system could exceed a total of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?